低级别蛛网膜下腔出血患者为何死亡
该回顾性研究纳入荷兰阿姆斯特丹与加拿大多伦多两个三级转诊中心2009至2013年入院时世界神经外科医师联盟分级IV或V级且住院期间死亡的连续蛛网膜下腔出血患者,357例中152例(43%)死亡,死亡主因为撤除生命支持(107例,71%),其次为脑死亡(23例,15%)。
要点
- 低级别蛛网膜下腔出血住院死亡患者中撤除生命支持占71%,为主要死因。
- 两中心撤除生命支持比例差异显著(阿姆斯特丹79% vs 多伦多58%,P<0.01)。
- 脑死亡占15%,两中心差异显著(阿姆斯特丹28% vs 多伦多7%,P<0.01)。
核心结论
- 撤除生命支持是低级别蛛网膜下腔出血患者死亡的绝大多数原因。
- 除文化与转诊差异外,撤除生命支持的确切原因尚未确定。
研究设计与样本
- 回顾性研究,纳入2009至2013年荷兰阿姆斯特丹与加拿大大多伦多两个三级转诊中心入院时世界神经外科医师联盟分级IV或V级且住院期间死亡的连续蛛网膜下腔出血患者,共357例。
主要发现
- 357例中152例(43%)死亡,其中87例(24%)未接受动脉瘤治疗。
- 死亡中位时间为初始出血后3天(四分位距1-12天)。
- 主要死因为撤除生命支持(107例,71%),其次为脑死亡(23例,15%),其余死因占比<15%。
关键数值与推荐
- 撤除生命支持:107例(71%);阿姆斯特丹74/94(79%),多伦多33/58(58%),P<0.01。
- 脑死亡:23例(15%);阿姆斯特丹16/58(28%),多伦多7/94(7%),P<0.01。
临床怎么用
- 临床中应关注低级别蛛网膜下腔出血患者撤除生命支持的决策过程及其原因。
- 研究提示需前瞻性研究死亡原因以改善此类患者的救治与临床结局。
局限性
- 原文未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Poor-grade subarachnoid hemorrhage (SAH) has been associated with a high case fatality, either in the acute phase or in the later stages. The exact causes of death in these patients are unknown. METHODS: We performed a retrospective study of all consecutive patients with SAH with World Federation of Neurosurgical Societies grade IV or V on admission from 2009 to 2013 at 2 tertiary referral centers in Amsterdam, the Netherlands, and Toronto, Ontario, Canada, who had died during their hospital stay. RESULTS: Of 357 patients, 152 (43%) had died. Of these 152 patients, 87 (24%) had not undergone aneurysm treatment. The median interval to death was 3 days (interquartile range, 1-12 days) after initial hemorrhage. The major cause of death in both centers was withdrawal of life support (107 patients [71%]; 74 of 94 [79%] in Amsterdam and 33 of 58 [58%] in Toronto; P < 0.01), followed by brain death in 23 (15%; 16 of 58 [28%] in Amsterdam vs. 7 of 94 [7%] in Toronto; P < 0.01). The remaining causes of death represented <15%. CONCLUSIONS: The decision to withdraw life support was the major reason for death of patients with poor-grade SAH for an overwhelming majority of the patients. The exact reasons for withdrawal of life support, other than cultural and referral differences, were undetermined. Insight into the reasons of death should be prospectively studied to improve the care and clinical outcomes of patients with poor-grade SAH.
引用
- Hoogmoed J, de Oliveira Manoel AL, Coert BA, et al. Why Do Patients with Poor-Grade Subarachnoid Hemorrhage Die? World Neurosurg. 2019. PMID: 31398522. doi:10.1016/j.wneu.2019.07.221
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。